Vivan Therapeutics raises €4.1M Series A round
10 February 2025· London, United Kingdom· health, oncology, biotech, ai, b2b, software_hardware
The funding will be used to establish cancer research labs in Abu Dhabi and collaborate with local medical centers to apply its personalized cancer-treatment technologies.
Investors
LeadHub71
Also participating
Reflect VenturesArben VenturesNevcapFreya VenturesGranatus Ventures
About Vivan Therapeutics
Stage
Series A
Headquarters
London, United Kingdom
Founded
2018
Team Size
21–50
Sectors
healthoncologybiotechaib2bsoftware_hardware
Source: https://waya.media/abu-dhabis-hub71-startups-reach-usd-2-45b-in-total-funding/